AbbVie | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Abbott USD 10.36B 610M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
J&J USD 21.89B 630M 2025-03
Medtronic USD 8.29B 111M 2025-01
Merck USD 15.53B 94M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
UCB EUR 2.79B 127M 2024-06
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Zoetis USD 2.32B 71M 2024-12



AbbVie Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.